INC Research Appoints New Chief Information Officer to Lead Data Intelligence Initiatives

INC Research Appoints New Chief Information Officer to Lead Data Intelligence Initiatives

Seasoned IT Leader to Drive Global Efficiency Using Advanced IT Strategies

Raleigh, N.C., Dec. 10, 2012 – INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced the appointment of Sal Chiovari as its new Chief Information Officer (CIO). Chiovari brings extensive experience in building high-performance teams and managing infrastructure services for global organizations and will lead the Company's worldwide Information Technology (IT) initiatives, including the development of new information systems architectures and strategic plans aimed at improving efficiency for clinical development programs.

"We are excited to have Sal on board. His expertise in infrastructure and process development, along with his experience in developing innovative technological solutions to drive efficiencies in delivery will be instrumental in evolving our Trusted Process®," said David Gill, Chief Financial Officer, INC Research. "With this appointment, INC Research continues to make important strides in becoming the global leader in data-driven intelligence to improve efficiency in clinical development and ultimately lead our customers to make better decisions even faster."

Chiovari brings more than 25 years of experience in IT leadership and data management to the role, including more than a decade of work related to the life sciences industry. He joins INC Research from Smith & Nephew, a global medical technology and devices company where he served as CIO. He also has served in senior IT positions at Primedia Corp. and Baxter International. Chiovari holds a bachelor's degree in business management from the University of Illinois.

INC Research provides the full range of Phase I to IV clinical development services across six continents using its Trusted Process® methodology − a proprietary process-oriented trial management approach that produces actionable data on time and on budget. For more information about the benefits of process-driven clinical research, please view our video or download our Trusted Process brochure.

About INC Research
INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in all therapeutic areas and innovative pediatric and women's health trials. The company's Trusted Process® methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit or follow us at @inc_research.

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today.

Suggested Articles

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.